Le Lézard
Classified in: Health
Subject: TRADE SHOWS/SEMINARS/WEBINARS

Q-Centrix Expert Spokesperson Available for Interviews at IHI National Forum


ORLANDO, FL--(Marketwired - December 07, 2017) - Q-Centrix's Chief Operating Officer, Patrick Herguth, is attending the 2017 Institute for Healthcare Improvement (IHI) National Forum on Quality Improvement in Health Care, Dec. 10?13, 2017, in Orlando, and available as a third-party source to reporters covering the meeting.

Herguth is an expert on efficiency and technology deployment for process performance improvement. He led a thought leadership session on quality measurement strategy at the Fall 2017 IHI Change Conference. He can address a range of healthcare quality topics to help audiences better understand industry issues.

The IHI National Forum on Quality Improvement in Health Care webpage is www.ihi.org/forum.

Image Available: http://www.marketwire.com/library/MwGo/2017/12/7/11G148614/Images/Patrick_Herguth-bb9b41c21a82b50e85c1495d22c54775.jpg


These press releases may also interest you

at 22:16
Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of Autoimmune Diseases of the Central Nervous System Published in Science Immunology
On May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of Science, published a research paper titled "Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system...

at 20:31
Club Studio Opens New Location in Kingwood, Texas
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. Announces Extension of Management Cease Trade Order
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

More news about Health...


News published on and distributed by: